Siblings Papers [0/1] Patents [0/11] Periodical Articles [193/194] Collection Statistics Item counts issued in 3 years:0(0.00%) Items With Fulltext:41(85.42%) Download counts of the item Download times greater than 0:41(100.00%) Download times greater than 100:41(100.00%) Total Bitstream Download Counts:24149(16.38%) Last Update: 2024-12-12 09:02 Top Upload Loading... Top Download Loading... Recent Submissions Cathepsin S inhibition alleviates o... Phase I study of biweekly liposome ... The clinical implication of O6 meth... O6BG modulates the repair activity ... Phase I dose-escalation study of so... Targeting cathepsin S induces tumor... MPT0B098, a novel microtubule inhib... Down-regulation of survivin enhance... Activation of NRF2/ABCC1 axis confe... DNA polymerase eta and a novel anti...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 48. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2019-07	Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942.
2018-12	The clinical implication of O6 methylguanine DNA methyltransferase in rectal cancers	Cancer Science. 2018 Dec;109(Suppl. 2):1369.
2018-01	O6BG modulates the repair activity of homologous recombination and its clinical application	Cancer Science. 2018 Jan;109(Suppl. 1):379.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2015-08	MPT0B292 enhances acetylation of alpha-tubulin through up-regulation of acetyltransferase gene, MEC-17 and exhibits potent anti-tumor, anti-angiogenesis and anti-metastatic effects in vitro and in vivo	Cancer Research. 2015 Aug;75(Suppl. 15):Abstract number 4379.
2015-05	Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595.
2015-04	The role of miR-450a in oral squamous cell carcinoma carcinogenesis	FASEB Journal. 2015 Apr;29(1, Suppl.):Abstract number 711.22.
2014-11	CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors	European Journal of Cancer. 2014 Nov;50(Suppl. 6):19-20.
2014-10	Genetic polymorphisms of genes on the retinoic acid pathway and risk of head and neck cancer	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4145.
2014-10	Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753.
2014-10	Identification of oral carcinoma miRNA signature and control OSCC tumorigenesis through Wnt/beta-catenin signaling	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 1487.
2014-06	Reconstruction of exposed cohort and cumulative dose of radio-contaminated building residents for epidemiological study - Updated information	Occupational and Environmental Medicine. 2014 Jun;71(Suppl. 1):A69.
2014-05	High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.
2013-06	Oral hygiene and risk of head and neck cancer	American Journal of Epidemiology. 2013 Jun;177(Suppl. 11):S58.
2013-04	Functional implication of TGFBR3 dysregulation and its clinical application in oral cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 3987.
2013-04	Generation and characterization of highly selective cathepsin S inhibitors with potentials against pancreatic cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 5562.
2013-04	EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
2013-04	Autophagy induced by cathepsin S inhibition causes early ROS production for oxidative DNA damage and subsequent cell death	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 1661.
2012-11	Overexpression of Discoidin Domain Receptor 1 (DDR1) in oral squamous cell carcinoma	European Journal of Cancer. 2012 Nov;48(Suppl. 6):167.
2012-11	Blockage of Nrf2/AKR1C axis enhanced therapeutic efficacy of oxaliplatin in oxaliplatin resistant gastric cancer cells	European Journal of Cancer. 2012 Nov;48(Suppl. 6):48.
2012-11	MicroRNA-99a, a tumor suppressor in oral squamous cell carcinoma regulates insulin-like growth factors I receptor in a double-negative feedback loop	European Journal of Cancer. 2012 Nov;48(Suppl. 6):120.
2012-04	DNA polymerase eta and a novel anticancer selenophene compound	Cancer Research. 2012 Apr;72:Abstract number 3813.
2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	Journal of Clinical Oncology. 2012 Feb;30(4):613.
2011-09-23	BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo	European Journal of Cancer. 2011 Sep 23;47:S127.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.

Showing items 1-25 of 48. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page